Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_device
gptkb:weight_management_aid |
| gptkbp:activeIngredient |
hydrogel
|
| gptkbp:approvalYear |
2019
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:indication |
obesity
overweight |
| gptkbp:intendedUse |
weight loss
|
| gptkbp:manufacturer |
gptkb:Gelesis
|
| gptkbp:mechanismOfAction |
expands in stomach to promote satiety
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:targetAudience |
adults with BMI 25-40 kg/m2
|
| gptkbp:bfsParent |
gptkb:Gelesis
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Plenity (2019)
|